Ardigen - TCR Therapies
From Immunology – TCR Therapies
Accelerate discovery and improve safety of TCR therapies using Artificial Intelligence. Following the unique opportunity for curing patients provided by the development of cell therapies (e.g. TCR discovery), Ardigen has set on the path to advance the field with its Artificial Intelligence platform. Many challenges stand in the way of successful therapy discovery and development. Let us know how we can help you!
-
Most popular related searches
Value We Deliver
- Refining selection and validation of the target pMHCs (peptide-Major Histocompatibility Complexes) with AI predictions
- Avoiding off-target immunotoxicity
- TCR discovery – accessing the full TCR (T-cell receptor) sequence space for hit identification
- Optimizing time and costs of TCR therapy development
Customer reviews
No reviews were found for Ardigen - TCR Therapies. Be the first to review!